Request a demo specialized to your need.
In a Tufts CSDD survey of 257 sponsors and CROs, the average time from last patient last visit to database lock was 36.3 days (Wilkinson et al., Therapeutic Innovation & Regulatory Science). In the EU, the trial master file must then be archived for at least 25 years after the trial ends (TransPerfect summary of EU TMF requirements), and a summary of results with a lay summary is due within 12 months of the end of the trial, or 6 months for paediatric trials (TrialAssure, EU CTR and CTIS).
Close-out gets less planning attention than start-up, yet it decides how quickly results reach regulators and how cleanly the trial will stand up to inspection years later. Most close-out delays come from work that could have been done during the trial. Here are seven tasks to keep on schedule.
Close-out at a glance
|
Task |
Owner |
What delays it |
|---|---|---|
|
Data cleaning and query closure |
Data management, sites, CRAs |
Open queries left until after the last visit |
|
Final source data review |
CRAs |
Backlog of unverified critical data |
|
Database lock |
Data management |
Late lab reconciliation or coding |
|
SAE reconciliation |
PV and data management |
EDC and safety database out of step |
|
Site close-out visits |
CRAs, sites |
ISF gaps and unreturned investigational product |
|
Final site payments |
Finance, study managers |
Unreconciled invoices and holdbacks |
|
TMF completion and archiving |
eTMF managers |
Documents missing or never QC'd |
1. Close queries during the trial, not after it
Every open query at last patient last visit is a task between you and database lock. Track query ageing by site through the study, and agree a target for the number of open queries at last visit.
2. Finish critical data review before the last visit
If source data review on critical data is up to date, the final monitoring visits confirm rather than discover. A backlog of unreviewed critical data at the end is one of the most common reasons lock slips.
3. Reconcile SAEs and coding early
Serious adverse events in EDC and the safety database must match before lock, and medical coding must be complete. Running reconciliation monthly during the trial leaves only the last few cases for close-out.
4. Plan site close-out visits with the site
The close-out visit checks that the investigator site file is complete, investigational product is reconciled and returned or destroyed, and the site understands its archiving responsibilities. Share the checklist with the site in advance so missing items are found before the visit.
5. Settle final site payments promptly
Final payments often include holdbacks, pass-through costs and last visits. Reconciling invoices during the trial makes the final payment a small step rather than a project, and closes the trial on good terms with the site.
6. Notify the end of the trial and plan results
Under the EU CTR, sponsors notify each Member State when the trial ends there, and the 12-month results clock starts from the end of the trial. Assign owners for the results summary and lay summary before the last visit.
7. Complete and archive the TMF
The TMF should be complete, QC'd and ready to archive with its metadata and audit trail. If a CRO holds the TMF, the transfer to the sponsor needs to be planned, including how documents and their history will move.
Close-out checklist
- Open query target agreed for last patient last visit
- Critical data review up to date at each site
- SAE reconciliation and medical coding complete
- Site close-out visit checklist shared with sites in advance
- Investigational product reconciled at every site
- Final invoices reconciled and holdbacks released
- End-of-trial notifications planned per country
- Results and lay summary owners assigned
- TMF QC complete, archive and transfer plan agreed
What this means by role
- Clinical operations directors and associate directors: close-out planning should start at the last patient first visit, not the last patient last visit.
- Clinical operations managers and CTMs: query ageing and payment reconciliation are the two trends to watch in the final months.
- CRAs: an up-to-date review backlog makes final visits short and close-out visits predictable.
- Clinical data managers: monthly reconciliation and coding leave a short path to lock.
- eTMF managers: TMF completeness and QC should be at target before the final visits begin.
- CRCs and principal investigators: a complete ISF and reconciled product make the close-out visit quick, and final payment follows faster.
- Quality and compliance directors: archiving and transfer plans are what an inspector will test years later.
How Cloudbyz approaches this
Cloudbyz builds CTMS, EDC, eTMF, CTFM and Safety & Pharmacovigilance natively on Salesforce, so close-out tasks across data, documents, payments and safety can be tracked on one platform. CTMS manages close-out visits and milestones by site, EDC supports query management, data review and data export, eTMF supports QC, completeness tracking and export with metadata and audit trail, and CTFM tracks site invoices and payments through to final settlement.
Book a demo or visit cloudbyz.com.
Subscribe to our Newsletter